Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

AIMS: Anacetrapib is an orally active and potent inhibitor of CETP in development for the treatment of dyslipidaemia. These studies endeavoured to establish the safety, tolerability, pharmacokinetics and pharmacodynamics of rising single doses of anacetrapib, administered in fasted or fed conditions...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Krishna, Rajesh, Garg, Amit, Panebianco, Deborah, Cote, Josee, Bergman, Arthur J, Van Hoydonck, Pascale, Laethem, Tine, Van Dyck, Kristien, Chen, Jingjing, Chavez-Eng, Cynthia, Archer, Laura, Lutz, Ryan, Hilliard, Deborah, Snyder, Karen, Jin, Bo, Van Bortel, Luc, Lasseter, Kenneth C, Al-Huniti, Nidal, Dykstra, Kevin, Gottesdiener, Keith, Wagner, John A
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2009
Teme:
Pharmacokinetics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2780279/
https://ncbi.nlm.nih.gov/pubmed/19843057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2009.03465.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items